ROBERT TEPPER

Profile

First Name

: ROBERT

Middle Name

:

Last Name

: TEPPER

Related Companies
Titles
Company Name
Related People
DIRECTOR
CERULEAN PHARMA INC.
STUART A. ARBUCKLE, GREGG BELOFF, CHERYL BLANCHARD, CHERYL R. BLANCHARD, ALEJANDRA V. CARVAJAL, ALAN CRANE, ALAN L. CRANE, DAVID P. DEMAGISTRIS, OLIVER FETZER, PAUL A. FRIEDMAN, EDWARD GARMEY, ALEXANDRA GLUCKSMANN, JESSICA GROSSMAN, JESSICA D. GROSSMAN, CHRISTOPHER D.T. GUIFFRE, STEVEN E. HALL, MARDEE HARING-LAYTON, ROGER L. HAWLEY, SABRINA MARTUCCI JOHNSON, SUSAN L. KELLEY, ROBERT LANGER, GREGORY W. MATZ, TERRY MCGUIRE, WILLIAM T. MCKEE, SOPHIA N. ONONYE-ONYIA, DAVID R. PARKINSON, ROBERT PAULL, WILLIAM H. RASTETTER, BRYAN E. ROBERTS, KAREN ROBERTS, JOHN RYAN, RAM SASISEKHARAN, ADRIAN SENDEROWICZ, JEAN SILVERI, ROBIN STEELE, ROBIN J. STEELE, DAVID R. WALT, LISA WALTERS-HOFFERT
DIRECTOR
ALNARA PHARMACEUTICALS INC
RICHARD H. ALDRICH, LEE BRETTMAN, ASHLEY DOMBKOWSKI, ROBERT GALLOTTO, ALEXEY MARGOLIN, JAMES N. TOPPER, CHRISTOPH H. WESTPHAL
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC
JAMES E. AUDIA, GAREN BOHLIN, SCOTT BRAUNSTEIN, MICHAEL R. COOPER, KEITH DIONNE, ANTHONY EVNIN, DAVID GOEDDEL, MARK A. GOLDSMITH, EDWARD E. HARLOW, JR., STEVEN HOERTER, MATTHIAS JAFFE, MARK LEVIN, TOM MANIATIS, STEVEN PAUL, JIGAR RAYTHATHA, EMMA REEVE, KERRY K. REINERTSEN, ADRIAN SENDEROWICZ, PETER SVENNILSON, ELIZABETH G. TREHU, PATRICK TROJER, KAREN VALENTINE
DIRECTOR
FOUNDATION MEDICINE, INC.
ALEXIS BORISY, ALEXIS BORISY, M.S., BROOK BYERS, ROBERT W. HESSLEIN, EVAN JONES, KEVIN KRENITSKY, KEVIN KRENITSKY, M.D., MARK LEVIN, MICHAEL J. PELLINI, MICHAEL PELLINI, M.D., JASON RYAN, DAVID SCHENKEIN, ROBERT TEPPER, M.D., KRISHNA YESHWANT
DIRECTOR
KALA PHARMACEUTICALS, INC.
TODD BAZEMORE, CHAIM BERGER, KEVIN BITTERMAN, MARK S. BLUMENKRANZ, KIM BRAZZELL, HONGMING CHEN, YONATAN COLMAN, PETER COUROSSI, MARJAN FARID, ANDREA FRANZ, BERNARD GILLY, GREG GRUNBERG, GREGORY GRUNBERG, JUSTIN HANES, MARK IWICKI, DARIUS KHARABI, ANDREW I. KOVEN, ANDREW L. KOVEN, ROBERT LANGER, DAVID LAZAR, CHARLES MCDERMOTT, AVI MINKOWITZ, C. DANIEL MYERS, ROBERT PAULL, GREGORY D. PERRY, GUILLAUME PFEFER, KEVIN POJASEK, HILLEL POSEN, BRENDAN PURDY, MARY REUMUTH, HOWARD B. ROSEN, RAJEEV SHAH, ERIC L. TRACHTENBERG, KAREN WAGNER, CHEN YU
DIRECTOR
BLUEBIRD BIO, INC.
JOHN AGWUNOBI, CHIP BAIRD, JASON COLE, WENDY DIXON, JAMES A. GERAGHTY, STEVEN GILLIS, RAMY IBRAHIM, NICK LESCHLY, DANIEL S. LYNCH, JOHN M. MARAGANORE, GEERT-JAN MULDER, AXEL POLACK, WILLIAM R. SELLERS, DENICE TORRES, MARK VACHON, JEFFREY T. WALSH
EXECUTIVE OFFICER
THIRD ROCK VENTURES III, L.P.
MARK LEVIN, KEVIN STARR, N/A THIRD ROCK VENTURES GP III, L.P., N/A TRV GP III, LLC
DIRECTOR
ALLENA PHARMACEUTICALS, INC.
AXEL BOLTE, LOUIS BRENNER, LOUIS BRENNER, M.D., ALLENE DIAZ, MARK FITZPATRICK, RICHARD D. KATZ, M.D., STEPHEN KRAUS, ALEXEY MARGOLIN, ANN C. MILLER, GINO SANTINI, JAMES TOPPER
DIRECTOR
JOUNCE THERAPEUTICS, INC.
ANNA L. BARRY, HUGH M. COLE, LUIS A. DIAZ, JR., KIM C. DRAPKIN, KIMBERLEE C. DRAPKIN, BARBARA DUNCAN, DUNCAN HIGGONS, ROBERT IANNONE, ROBERT KAMEN, PERRY KARSEN, RICHARD MURRAY, CARY PFEFFER, CARY G. PFEFFER, ELIZABETH G. TREHU
EXECUTIVE OFFICER
THIRD ROCK VENTURES IV, L.P.
ALEXIS BORISY, ABBIE CELNIKER, CRAIG MUIR, CARY PFEFFER, N/A THIRD ROCK VENTURES GP IV, L.P., N/A TRV GP IV, LLC
DIRECTOR
NEON THERAPEUTICS, INC.
YASIR AL-WAKEEL, ROBERT ANG, M.D., DANIELLA BECKMAN, HUGH DOWD, RICHARD GAYNOR, M.D., ROBERT KAMEN, ERIC LANDER, CARY PFEFFER, M.D., STEPHEN SHERWIN
EXECUTIVE OFFICER
THIRD ROCK VENTURES V, L.P.
ABBIE CELNIKER, NEIL EXTER, KEVIN GILLIS, REID HUBER, STEVEN KAFKA, SARAH LARSON, CHRISTOPH LENGAUER, CRAIG MUIR, CARY PFEFFER, N/A THIRD ROCK VENTURES GP V, L.P., JEFFREY TONG, N/A TRV GP V, LLC
DIRECTOR
FAZE MEDICINES, INC.
ED FREEDMAN, CHARLES HOMCY, CARY PFEFFER
EXECUTIVE OFFICER
THIRD ROCK VENTURES VI, L.P.
ABBIE CELNIKER, NEIL EXTER, KEVIN GILLIS, REID HUBER, DAVID KAUFMAN, CARY PFEFFER, N/A THIRD ROCK VENTURES GP VI, L.P., JEFFREY TONG, N/A TRV GP VI, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-06-10
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-05-26 
2020-12-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-08 
2020-10-29
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-10-16 
2019-10-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-10-01 
2019-06-07
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2019-05-23 
2018-04-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-22 
2017-12-13
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-12-28 
2017-01-11
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-28 
2016-11-02
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2016-10-28 
2016-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-13 
2016-04-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-04-06 
2015-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-01 
2015-12-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-25 
2015-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-17 
2015-04-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-17 
2014-11-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-29 
2014-08-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-05 
2014-04-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-16 
2013-03-25
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2013-03-15 
2013-02-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-14 
2012-12-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-30 
2012-07-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-23 
2012-03-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-29 
2011-12-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-02 
2011-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-23 
2011-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2011-04-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-05 
2010-11-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-12 
2010-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-10-26 
2010-10-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-29 
2010-06-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-26 
2010-06-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-24 
2010-04-15
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-03-31 
2010-02-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-25 
2009-07-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-13